|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Lieberman D: Progress and challenges in
colorectal cancer screening and surveillance. Gastroenterology.
138:2115–2126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leonard GD, Brenner B and Kemeny NE:
Neoadjuvant chemotherapy before liver resection for patients with
unresectable liver metastases from colorectal carcinoma. J Clin
Oncol. 23:2038–2048. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mahmoud N and Bullard Dunn K:
Metastasectomy for stage IV colorectal cancer. Dis Colon Rectum.
53:1080–1092. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stangl R, Altendorf-Hofmann A, Charnley RM
and Scheele J: Factors influencing the natural history of
colorectal liver metastases. Lancet. 343:1405–1410. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fortner JG, Silva JS, Golbey RB, Cox EB
and Maclean BJ: Multivariate analysis of a personal series of 247
consecutive patients with liver metastases from colorectal cancer.
I Treatment by hepatic resection. Ann Surg. 199:306–316. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scheele J, Stang R, Altendorf-Hofmann A
and Paul M: Resection of colorectal liver metastases. World J Surg.
19:59–71. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomlinson JS, Jarnagin WR, DeMatteo RP, et
al: Actual 10-year survival after resection of colorectal liver
metastases defines cure. J Clin Oncol. 25:4575–4580.
2007.PubMed/NCBI
|
|
9
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kabbinavar F, Hurwitz HI, Fehrenbacher L,
et al: Phase II, randomized trial comparing bevacizumab plus
fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with
metastatic colorectal cancer. J Clin Oncol. 21:60–65. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kabbinavar FF, Hambleton J, Mass RD,
Hurwitz HI, Bergsland E and Sarkar S: Combined analysis of
efficacy: the addition of bevacizumab to fluorouracil/leucovorin
improves survival for patients with metastatic colorectal cancer. J
Clin Oncol. 23:3706–3712. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Allegra CJ, Yothers G, O’Connell MJ, et
al: Phase III trial assessing bevacizumab in stages II and III
carcinoma of the colon: results of NSABP protocol C-08. J Clin
Oncol. 29:11–16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van de Veire S, Stalmans I, Heindryckx F,
et al: Further pharmacological and genetic evidence for the
efficacy of PlGF inhibition in cancer and eye disease. Cell.
141:178–190. 2010.PubMed/NCBI
|
|
14
|
Cirulli V and Yebra M: Netrins: beyond the
brain. Nat Rev Mol Cell Biol. 8:296–306. 2007. View Article : Google Scholar
|
|
15
|
Dumartin L, Quemener C, Laklai H, et al:
Netrin-1 mediates early events in pancreatic adenocarcinoma
progression, acting on tumor and endothelial cells.
Gastroenterology. 138:1595–1606. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lejmi E, Leconte L, Pedron-Mazoyer S, et
al: Netrin-4 inhibits angiogenesis via binding to neogenin and
recruitment of Unc5B. Proc Natl Acad Sci USA. 105:12491–12496.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nacht M, St Martin TB, Byrne A, Klinger
KW, Teicher BA, Madden SL and Jiang Y: Netrin-4 regulates
angiogenic responses and tumor cell growth. Exp Cell Res.
315:784–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eveno C, Broqueres-You D, Feron JG, et al:
Netrin-4 delays colorectal cancer carcinomatosis by inhibiting
tumor angiogenesis. Am J Pathol. 178:1861–1869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoffman RM: Orthotopic metastatic mouse
models for anticancer drug discovery and evaluation: a bridge to
the clinic. Invest New Drugs. 17:343–359. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miles D, Harbeck N, Escudier B, et al:
Disease course patterns after discontinuation of bevacizumab:
pooled analysis of randomized phase III trials. J Clin Oncol.
29:83–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen HX and Cleck JN: Adverse effects of
anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol.
6:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gressett SM and Shah SR: Intricacies of
bevacizumab-induced toxicities and their management. Ann
Pharmacother. 43:490–501. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Higa GM and Abraham J: Biological
mechanisms of bevacizumab-associated adverse events. Expert Rev
Anticancer Ther. 9:999–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ranpura V, Hapani S and Wu S:
Treatment-related mortality with bevacizumab in cancer patients: a
meta-analysis. JAMA. 305:487–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zangari M, Fink LM, Elice F, Zhan F,
Adcock DM and Tricot GJ: Thrombotic events in patients with cancer
receiving antiangiogenesis agents. J Clin Oncol. 27:4865–4873.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eikesdal HP and Kalluri R: Drug resistance
associated with antiangiogenesis therapy. Semin Cancer Biol.
19:310–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eichmann A, Makinen T and Alitalo K:
Neural guidance molecules regulate vascular remodeling and vessel
navigation. Genes Dev. 19:1013–1021. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Larrivee B, Freitas C, Trombe M, et al:
Activation of the UNC5B receptor by Netrin-1 inhibits sprouting
angiogenesis. Genes Dev. 21:2433–2447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu X, Le Noble F, Yuan L, et al: The
netrin receptor UNC5B mediates guidance events controlling
morphogenesis of the vascular system. Nature. 432:179–186. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wilson BD, Ii M, Park KW, et al: Netrins
promote developmental and therapeutic angiogenesis. Science.
313:640–644. 2006. View Article : Google Scholar : PubMed/NCBI
|
